Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer; - The pre-defined disease control efficacy threshold in part 1 in the colorectal cancer cohort has been met

Media coverage

• Title	Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer; - The pre-defined disease control efficacy threshold in part 1 in the colorectal cancer cohort has been met
  Media name/outlet	PR Newswire
  Country/Territory	United States
  Date	13/10/20
  Persons	Dmitriy Zamarin

• Title	Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer
  Media name/outlet	PR Newswire European (Top News)
  Country/Territory	United Kingdom
  Date	13/10/20
  Persons	Dmitriy Zamarin

• Title	Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer
  Media name/outlet	Cision Nordic Companies Press Releases (Scandinavia)
  Country/Territory	Denmark
  Date	13/10/20
  Persons	Dmitriy Zamarin